2025-04-012026-03-312026-03-31false12274913PJ AND CJ LIMITED2026-08-10falseiso4217:GBPxbrli:pure122749132025-03-31122749132026-03-31122749132025-04-012026-03-31122749132024-03-31122749132025-03-31122749132024-04-012025-03-3112274913bus:SmallEntities2025-04-012026-03-3112274913bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3112274913bus:FullAccounts2025-04-012026-03-3112274913bus:PrivateLimitedCompanyLtd2025-04-012026-03-3112274913core:WithinOneYear2026-03-3112274913core:AfterOneYear2026-03-3112274913core:WithinOneYear2025-03-3112274913core:AfterOneYear2025-03-3112274913core:ShareCapital2026-03-3112274913core:SharePremium2026-03-3112274913core:RevaluationReserve2026-03-3112274913core:OtherReservesSubtotal2026-03-3112274913core:RetainedEarningsAccumulatedLosses2026-03-3112274913core:ShareCapital2025-03-3112274913core:SharePremium2025-03-3112274913core:RevaluationReserve2025-03-3112274913core:OtherReservesSubtotal2025-03-3112274913core:RetainedEarningsAccumulatedLosses2025-03-3112274913core:LandBuildings2026-03-3112274913core:PlantMachinery2026-03-3112274913core:Vehicles2026-03-3112274913core:FurnitureFittings2026-03-3112274913core:OfficeEquipment2026-03-3112274913core:NetGoodwill2026-03-3112274913core:IntangibleAssetsOtherThanGoodwill2026-03-3112274913core:ListedExchangeTraded2026-03-3112274913core:UnlistedNon-exchangeTraded2026-03-3112274913core:LandBuildings2025-03-3112274913core:PlantMachinery2025-03-3112274913core:Vehicles2025-03-3112274913core:FurnitureFittings2025-03-3112274913core:OfficeEquipment2025-03-3112274913core:NetGoodwill2025-03-3112274913core:IntangibleAssetsOtherThanGoodwill2025-03-3112274913core:ListedExchangeTraded2025-03-3112274913core:UnlistedNon-exchangeTraded2025-03-3112274913core:LandBuildings2025-04-012026-03-3112274913core:PlantMachinery2025-04-012026-03-3112274913core:Vehicles2025-04-012026-03-3112274913core:FurnitureFittings2025-04-012026-03-3112274913core:OfficeEquipment2025-04-012026-03-3112274913core:NetGoodwill2025-04-012026-03-3112274913core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3112274913core:ListedExchangeTraded2025-04-012026-03-3112274913core:UnlistedNon-exchangeTraded2025-04-012026-03-3112274913core:MoreThanFiveYears2025-04-012026-03-3112274913core:Non-currentFinancialInstruments2026-03-3112274913core:Non-currentFinancialInstruments2025-03-3112274913dpl:CostSales2025-04-012026-03-3112274913dpl:DistributionCosts2025-04-012026-03-3112274913core:LandBuildings2025-04-012026-03-3112274913core:PlantMachinery2025-04-012026-03-3112274913core:Vehicles2025-04-012026-03-3112274913core:FurnitureFittings2025-04-012026-03-3112274913core:OfficeEquipment2025-04-012026-03-3112274913dpl:AdministrativeExpenses2025-04-012026-03-3112274913core:NetGoodwill2025-04-012026-03-3112274913core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3112274913dpl:GroupUndertakings2025-04-012026-03-3112274913dpl:ParticipatingInterests2025-04-012026-03-3112274913dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3112274913core:ListedExchangeTraded2025-04-012026-03-3112274913dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3112274913core:UnlistedNon-exchangeTraded2025-04-012026-03-3112274913dpl:CostSales2024-04-012025-03-3112274913dpl:DistributionCosts2024-04-012025-03-3112274913core:LandBuildings2024-04-012025-03-3112274913core:PlantMachinery2024-04-012025-03-3112274913core:Vehicles2024-04-012025-03-3112274913core:FurnitureFittings2024-04-012025-03-3112274913core:OfficeEquipment2024-04-012025-03-3112274913dpl:AdministrativeExpenses2024-04-012025-03-3112274913core:NetGoodwill2024-04-012025-03-3112274913core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3112274913dpl:GroupUndertakings2024-04-012025-03-3112274913dpl:ParticipatingInterests2024-04-012025-03-3112274913dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3112274913core:ListedExchangeTraded2024-04-012025-03-3112274913dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3112274913core:UnlistedNon-exchangeTraded2024-04-012025-03-3112274913core:NetGoodwill2026-03-3112274913core:IntangibleAssetsOtherThanGoodwill2026-03-3112274913core:LandBuildings2026-03-3112274913core:PlantMachinery2026-03-3112274913core:Vehicles2026-03-3112274913core:FurnitureFittings2026-03-3112274913core:OfficeEquipment2026-03-3112274913core:AfterOneYear2026-03-3112274913core:WithinOneYear2026-03-3112274913core:ListedExchangeTraded2026-03-3112274913core:UnlistedNon-exchangeTraded2026-03-3112274913core:ShareCapital2026-03-3112274913core:SharePremium2026-03-3112274913core:RevaluationReserve2026-03-3112274913core:OtherReservesSubtotal2026-03-3112274913core:RetainedEarningsAccumulatedLosses2026-03-3112274913core:NetGoodwill2025-03-3112274913core:IntangibleAssetsOtherThanGoodwill2025-03-3112274913core:LandBuildings2025-03-3112274913core:PlantMachinery2025-03-3112274913core:Vehicles2025-03-3112274913core:FurnitureFittings2025-03-3112274913core:OfficeEquipment2025-03-3112274913core:AfterOneYear2025-03-3112274913core:WithinOneYear2025-03-3112274913core:ListedExchangeTraded2025-03-3112274913core:UnlistedNon-exchangeTraded2025-03-3112274913core:ShareCapital2025-03-3112274913core:SharePremium2025-03-3112274913core:RevaluationReserve2025-03-3112274913core:OtherReservesSubtotal2025-03-3112274913core:RetainedEarningsAccumulatedLosses2025-03-3112274913core:NetGoodwill2024-03-3112274913core:IntangibleAssetsOtherThanGoodwill2024-03-3112274913core:LandBuildings2024-03-3112274913core:PlantMachinery2024-03-3112274913core:Vehicles2024-03-3112274913core:FurnitureFittings2024-03-3112274913core:OfficeEquipment2024-03-3112274913core:AfterOneYear2024-03-3112274913core:WithinOneYear2024-03-3112274913core:ListedExchangeTraded2024-03-3112274913core:UnlistedNon-exchangeTraded2024-03-3112274913core:ShareCapital2024-03-3112274913core:SharePremium2024-03-3112274913core:RevaluationReserve2024-03-3112274913core:OtherReservesSubtotal2024-03-3112274913core:RetainedEarningsAccumulatedLosses2024-03-3112274913core:AfterOneYear2025-04-012026-03-3112274913core:WithinOneYear2025-04-012026-03-3112274913core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3112274913core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3112274913core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3112274913core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3112274913core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3112274913core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3112274913core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3112274913core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3112274913core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3112274913core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3112274913core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3112274913core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3112274913core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3112274913core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3112274913core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3112274913core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3112274913core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3112274913core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3112274913core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3112274913core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3112274913core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3112274913core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3112274913core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3112274913core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3112274913core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3112274913core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3112274913core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3112274913bus:Director12025-04-012026-03-3112274913bus:Director22025-04-012026-03-31

PJ AND CJ LIMITED

Registered Number
12274913
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

PJ AND CJ LIMITED
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

Dr Claire Joanna Nixon
Dr Peter John Nixon

Registered Address

Fulford Lodge Fulford Lodge
1 Heslington Lane
Fulford
YO10 4HW

Registered Number

12274913 (England and Wales)
PJ AND CJ LIMITED
Statement of Financial Position
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets3234,982235,543
234,982235,543
Current assets
Debtors419,28424,862
Cash at bank and on hand107,15096,085
126,434120,947
Creditors amounts falling due within one year5(40,818)(28,113)
Net current assets (liabilities)85,61692,834
Total assets less current liabilities320,598328,377
Provisions for liabilities6(487)(611)
Net assets320,111327,766
Capital and reserves
Called up share capital100100
Profit and loss account320,011327,666
Shareholders' funds320,111327,766
The financial statements were approved and authorised for issue by the Board of Directors on 10 August 2026, and are signed on its behalf by:
Dr Claire Joanna Nixon
Director
Dr Peter John Nixon
Director

Registered Company No. 12274913
PJ AND CJ LIMITED
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
The UK economy continues to face a degree of economic uncertainty, including the ongoing effects of inflation, interest rates and energy costs. These factors have affected the company's trading results to varying degrees. In preparing these financial statements, the directors have considered the potential impact of these matters based on the information available at the date of approval and do not believe they will affect the company's ability to continue trading for the foreseeable future. Accordingly, at the date of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for at least 12 months from the date of approval of these financial statements. The directors have therefore prepared the financial statements on a going concern basis.
Turnover policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion. The company generates rental income from leasing its property to a long-term tenant.
Revenue from sale of goods
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Reducing balance (%)
Plant and machinery20
Office Equipment20
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20262025
Average number of employees during the year11
3.Tangible fixed assets

Land & buildings

Plant & machinery

Office Equipment

Total

££££
Cost or valuation
At 01 April 25232,7394,437429237,605
At 31 March 26232,7394,437429237,605
Depreciation and impairment
At 01 April 25-1,7742882,062
Charge for year-53328561
At 31 March 26-2,3073162,623
Net book value
At 31 March 26232,7392,130113234,982
At 31 March 25232,7392,663141235,543
4.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables19,12724,862
Other debtors157-
Total19,28424,862
5.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables1,6676,417
Taxation and social security16,94817,375
Other creditors20,3532,787
Accrued liabilities and deferred income1,8501,534
Total40,81828,113
6.Provisions for liabilities

2026

2025

££
Other provisions487611
Total487611
7.Related party transactions
During the year the Directors loaned the company £20,353 (2025: £2,787). This loan is repayable upon demand. Interest was charged on the loan balance at the UK market rate on a monthly basis. The balance of this loan is included in other creditors.